Overall, 55 different treatment modalities, including topical, ultraviolet-based, systemic, and other miscellaneous therapies were assessed.
EENT = Eye, ear, nose, and throat conditions * Miscellaneous CAM therapies include: multivitamins, shoe orthoses, electrodermal screening, and aromatherapy.
Interventions (treatment, strategy, procedure) were classified as follow: vasopressors; fluid loading/global hemodynamic-based strategy; steroids; antimicrobial agents; modulation of immunity; coagulation-targeted therapy; miscellaneous.
At the time of data analysis, most patients were off study with disease progression or death (82%), whereas adverse events, withdrawal of consent, completion of planned therapy, and miscellaneous factors accounted for 8, 5, 3, and 3% of study discontinuations, respectively.
The identified subheadings were: Nervous System; Skin; Skeleton; Renal/Ureter/Bladder; Fertility/Pregnancy; Miscellaneous (this included such codes as oncology related therapies); Eyes; Ears; Respiratory; Cardiac; Gastrointestinal; Pelvic/Sphincter/Urethral; Lymphatics; Breast; Psychiatric and Male Specific Codes.
During the intervening period, providers typically use nonspecific (or miscellaneous) codes that may also be used for other therapies.
Twenty-two percent of patients had extrapulmonary disease amenable to local therapy including 49 liver, 16 bone and 60 miscellaneous metastases.
These studies are grouped into the following categories: cardiovascular therapies, mechanical therapies, pathophysiologic mechanisms, hemodynamic monitoring, ultrasound in respiratory failure, microcirculation, and miscellaneous.
Pharmacologic diarrhea therapy include antimotility, spasmolytic, antisecretory, adsorbents, probiotics, anti-infective and miscellaneous agents like α2-adrenergic receptor antagonist, Ca2+ channel blockers and calmodulin inhibitors [ 30, 31].
One hundred twenty-five patients (22%) had extrapulmonary active disease amenable to local therapy (RFA or surgery) including 49 liver, 16 bone and 60 miscellaneous metastases.
